El objeto del contrato viene determinado por el suministro de los principios activos denominados "RISDIPLAM 60MG/80ML ORAL" y"PERTUZUMAB 1200 MG / TRASTUZUMAB 600 MG SC".

Contract type	Supplies
CPV	33690000
Awarded to	Roche Farma, S.A.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.